The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ESH MM 2018 | Smoldering multiple myeloma: what is the current definition & new screening programme
Speaking from the European School of Haematology (ESH) International Conference on Multiple Myeloma 2018, held in Mandelieu, France, Irene Ghobrial, MD, from the Dana-Farber Cancer Institute, Boston, MA, discusses the current definitions of smoldering multiple myeloma (MM) and high-risk smoldering MM. She emphasizes the need to incorporate criteria for genomic alterations into these definitions and highlights an upcoming screening project that her center will be running, using a Stand Up to Cancer (SU2C) grant, which will screen those at high-risk of developing MGUS and smoldering MM, and investigate the underlying genetic predispositions for this.
